Yunfeng Shen

1. SGLT2 inhibitor empagliflozin downregulates miRNA-34a-5p and targets GREM2 to inactivate hepatic stellate cells and ameliorate non-alcoholic fatty liver disease-associated fibrosis
   2023/07/06 by Yunfeng Shen, Lidan Cheng, Minxuan Xu +6 · 2 citations
   Medicine · #Liver physiology and pathology #Liver Disease Diagnosis and Treatment #Liver Diseases and Immunity